Palo Alto Investors LP 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:52 pm Sale | 2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 340,146 4.450% | -24,551 (-6.73%) | Filing |
| 2022-02-14 5:09 pm Purchase | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 364,697 7.240% | 13,520 (+3.85%) | Filing |
| 2021-02-16 4:41 pm Purchase | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 351,177 7.160% | 44,843 (+14.64%) | Filing |